资本集团目前在丹麦生物技术公司新西兰制药拥有6.20%的表决权。 Capital Group now holds 6.20% of voting rights in Danish biotech firm Zealand Pharma.

资本集团公司公司宣布,他们在新西兰药店A/S拥有6.20%的表决权。 新西兰药店A/S是一家设在哥本哈根的生物技术公司,重点是开发以浸药为基础的药物。 The Capital Group Companies, Inc. announced they hold 6.20% of voting rights in Zealand Pharma A/S, a Copenhagen-based biotech company focused on developing peptide-based medicines. 新西兰制药公司有10多个药物候选者正在开发中,其中2个在市场上,3个在后期开发中。 Zealand Pharma has over 10 drug candidates in development, with two on the market and three in late-stage development. 该公司还与各种制药公司保持伙伴关系。 The company also maintains partnerships with various pharmaceutical firms.